1. Home
  2. AZTR vs LICN Comparison

AZTR vs LICN Comparison

Compare AZTR & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • LICN
  • Stock Information
  • Founded
  • AZTR 2014
  • LICN 2004
  • Country
  • AZTR United States
  • LICN China
  • Employees
  • AZTR 12
  • LICN N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • AZTR Health Care
  • LICN
  • Exchange
  • AZTR Nasdaq
  • LICN Nasdaq
  • Market Cap
  • AZTR 4.0M
  • LICN 3.6M
  • IPO Year
  • AZTR 2023
  • LICN 2023
  • Fundamental
  • Price
  • AZTR $0.26
  • LICN $4.25
  • Analyst Decision
  • AZTR
  • LICN
  • Analyst Count
  • AZTR 0
  • LICN 0
  • Target Price
  • AZTR N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • AZTR 4.6M
  • LICN 75.2K
  • Earning Date
  • AZTR 08-11-2025
  • LICN 01-01-0001
  • Dividend Yield
  • AZTR N/A
  • LICN N/A
  • EPS Growth
  • AZTR N/A
  • LICN N/A
  • EPS
  • AZTR N/A
  • LICN N/A
  • Revenue
  • AZTR $7,500.00
  • LICN $41,477,000.00
  • Revenue This Year
  • AZTR N/A
  • LICN N/A
  • Revenue Next Year
  • AZTR N/A
  • LICN N/A
  • P/E Ratio
  • AZTR N/A
  • LICN N/A
  • Revenue Growth
  • AZTR N/A
  • LICN 4.32
  • 52 Week Low
  • AZTR $0.23
  • LICN $2.60
  • 52 Week High
  • AZTR $12.00
  • LICN $488.00
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 46.07
  • LICN 47.63
  • Support Level
  • AZTR $0.23
  • LICN $3.80
  • Resistance Level
  • AZTR $0.36
  • LICN $4.26
  • Average True Range (ATR)
  • AZTR 0.02
  • LICN 0.33
  • MACD
  • AZTR -0.00
  • LICN -0.03
  • Stochastic Oscillator
  • AZTR 26.79
  • LICN 37.85

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: